The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 110
Healthy Volunteers: f
View:
• Age above 18 years and consentable
• Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
• Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
• Written informed consent
Locations
Other Locations
Germany
Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München
RECRUITING
Munich
Contact Information
Primary
Patrick Mayr, MD
mayrp@dhm.mhn.de
+498912180
Backup
Joner Michael, Prof
joner@dhm.mhn.de
+498912180
Time Frame
Start Date: 2020-09-15
Estimated Completion Date: 2031-01-01
Participants
Target number of participants: 5000
Related Therapeutic Areas
Sponsors
Leads: Deutsches Herzzentrum Muenchen